Course director, Head Health Economics Outcomes Research & Epidemiology, Idorsia, Switzerland
Market Access for Pharmaceutical Products - Trends and Challenges
In recent years, the field of pricing and reimbursement of pharmaceuticals has become more complex and challenging.
This course is a part of
In the competitive world of pharmaceutical sales, developing a market access strategy and communicating the value of the brands to the ‘payers’ is at the top of the agenda. In recent years, the field of pricing and reimbursement of pharmaceuticals has become more complex and challenging.
The economic pressures and general demographic changes coupled with highly innovative and more expensive drugs has contributed to bigger hurdles in securing market access. Decisions are now increasingly made on cost-effectiveness and cost-containment rationales.
Although everyone seems to be talking about market access, very few are able to define it. Who are the key stakeholders, exactly? Is it no longer the prescribers that decide which drug a patient should use? Is market access only about containing costs for the public budgets or are the benefits for patients and society as well?
This course will provide insight into the key principles and a practical understanding of ‘market access’ as it relates to the pharmaceutical industry. The course starts with an overview of the key stakeholders and current trends in the global market access of pharmaceuticals followed by a review of the challenges and relevant issues through a combination of lectures, discussions, group work, and case studies.
The topics include:
- Introduction to market access - marketing trends, defining global market access for the 21st century, its importance for optimizing product launches and its implications for the entire organization.
- Core concepts of market access – defining the concepts, theories and methods relevant for the pharmaceutical industry.
- Value generation – the role of clinical trials, real-world evidence, life-cycle management and health economics.
- Stakeholders – who they are, their perspectives, how and when to engage with ‘payers’.
- Health economic aspects of market access ;– economic and financial considerations, core concepts and vocabulary.
- Pricing and reimbursement – global vs. local optimization, reference pricing systems in various markets.
- Important decision makers in selected countries
- Trends in key markets
- Patient centricity – the importance of understanding that the end-user must be the focal point of the entire process.
I have over the years participated in numerous courses at different universities and venues. The service, faculty, catering and facilities at “Copenhagen Summer University” stand out as the best of them all”
I think this course has been covering all the different perspectives of market Access
I really enjoyed the course. It touched every subject related to market acces
Course Directors and Lecturers - Market Access
Learning outcomes of - Market Access
Course Information - Market Access
Schedule and delivery
Dates
26-04-2027 08:15-17:00
27-04-2027 08:15-17:00
28-04-2027 08:15-17:00
29-04-2027 08:15-17:00
30-04-2027 08-15-17:00
Teaching methods
The course is organized as an intensive 5-day course and comprises lectures, group work, case studies and discussions.
The compulsory syllabus comprises a collection of scientific articles, review papers and case studies corresponding to approximately 500 pages (extra 200 pages self-selected literature for the optional exam).
Target audience
The course is designed as continuing professional development for professionals in the pharmaceutical industry, particularly in regulatory affairs, medical affairs and sales and marketing, including decision-makers and administrators in the public and private sectors.
The course offers an excellent introduction for those less familiar with market access and will provide a deeper understanding for those with experience within administration and marketing. Please note, the course is not an advanced course for market access specialists.
Admission requirements
You must meet the following criteria to be admitted to this course:
-
Have a bachelor's degree, a professional bachelor’s degree, a diploma degree, a master’s degree or equivalent within chemistry, biochemistry, pharmacy, medicine, biomedicine, human biology, molecular biology, veterinary sciences, health sciences, nursing, engineering or equivalent.
-
Have at least two years of relevant work experience related to development of medicines
-
Be proficiency in English
Fee
EU/EEA citizens
14.450 DKK
Non-EU/EEA citizens
16.580
Location
University of Copenhagen
Department of Pharmacy/
Department of Drug Design and Pharmacology
Universitetsparken 2
2100 Copenhagen
Denmark
Contact
University of Copenhagen
Continuing and Lifelong Learning
lifelonglearning@adm.ku.dk